Cell Sorting Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product and Services (Cell Sorters, Reagents and Kits, Consumables, Cell Sorting Services), By Technology (Fluorescence- Based Droplet Cell Sorting, Magnetic-Activated Cell Sorting (MACS), Micro-Electromechanical Systems (MEMS)–Microfluidics), By Application (Research (Immunology & Cancer Research, Stem Cell Research, Drug Discovery, others), Clinical), By End User (Research Institutes, Pharmaceutical and Biotechnology Companies, Medical and Academic Institutions, Hospitals and Clinical, Others), By Region, and By Competition, 2020-2030F

Market Overview

The Global Cell Sorting Market, valued at USD 456.76 Million in 2024, is projected to experience a CAGR of 5.77% to reach USD 639.56 Million by 2030. Cell sorting is a laboratory technique employed for the isolation and separation of specific cell populations from heterogeneous biological samples based on their distinct physical, biochemical, or functional characteristics, critical for advancing various biomedical and research applications. The market’s growth is primarily supported by the escalating prevalence of chronic diseases, necessitating advanced diagnostics and targeted therapies, alongside continuous research and development in immunology, oncology, and regenerative medicine. According to the International Society for Advancement of Cytometry, the organization reported $2.65 million in revenue during 2023, reflecting significant operational activity within the professional body that supports the broader cytometry industry, including cell sorting technologies.

However, the global cell sorting market expansion faces a notable impediment due to the substantial initial capital investment required for sophisticated cell sorting instruments and the ongoing operational costs, which can limit adoption in certain research or clinical settings. Additionally, the requirement for highly skilled personnel to operate and maintain these complex systems presents a barrier, particularly in regions with limited technical expertise.

Key Market Drivers

The global cell sorting market is significantly propelled by continuous technological advancements in cell sorting platforms. These innovations enhance the precision, speed, and multiplexing capabilities of cell sorters, enabling researchers to isolate increasingly rare and specific cell populations for in-depth analysis and therapeutic development. Developments include the integration of spectral flow cytometry and real-time image-based sorting, which provide more comprehensive cellular insights and improve workflow automation. Such advancements directly influence market expansion by offering solutions that were previously unattainable, fostering new research applications and clinical diagnostic methods. Companies are actively investing in these areas; for instance, according to Cytek Biosciences' Fourth Quarter and Full Year 2023 Financial Results, released in February 2024, the company reported research and development expenses of $44.2 million for the year ended December 31, 2023, reflecting ongoing commitment to innovation in cell analysis technologies.

Another pivotal driver is the increasing prevalence of chronic diseases and cancer, which necessitates advanced diagnostic tools, improved disease monitoring, and the development of targeted cell-based therapies. Cell sorting plays a critical role in isolating disease-specific cells, identifying biomarkers, and preparing cells for therapeutic interventions such as CAR T-cell therapy. The substantial global burden of these diseases creates an urgent demand for more effective and efficient cell isolation techniques. According to the World Health Organization and International Agency for Research on Cancer, in February 2024, there were an estimated 20 million new cancer cases globally in 2022, underscoring the pressing need for sophisticated biomedical research tools and clinical applications to combat such conditions. Supporting this extensive research landscape, according to the American Society for Radiation Oncology, in March 2024, Congressional appropriations for Fiscal Year 2024 included $48.6 billion for the National Institutes of Health (NIH), with the National Cancer Institute (NCI) receiving a $120 million increase, demonstrating substantial government investment in biomedical R&D that benefits the broader cell sorting market.

Download Free Sample Report

Key Market Challenges

The substantial initial capital investment required for cell sorting instruments, alongside ongoing operational expenditures, presents a significant impediment to the expansion of the Global Cell Sorting Market. This financial hurdle restricts the adoption of these essential technologies, particularly within smaller research laboratories, emerging clinical facilities, and academic institutions operating with constrained budgets. The considerable cost of acquiring advanced cell sorting platforms, which can entail several hundred thousand dollars or more per unit, substantially limits the number of organizations able to implement them.

Moreover, the cumulative effect of associated costs for specialized reagents, consumables, and routine maintenance further exacerbates this financial strain. According to AdvaMed's 2023 Pulse of the Industry report, the broader medical technology sector experienced a 30% decline in overall industry financing in 2022, with venture capital funding specifically decreasing by 21% during the same period. This trend reflects a challenging investment environment that directly intensifies the difficulty of securing the considerable upfront and recurring funds necessary for developing and maintaining cell sorting infrastructure, consequently decelerating market growth by constraining new installations and upgrades globally.

Key Market Trends

The integration of artificial intelligence and automation is a significant trend, enhancing the precision, throughput, and analytical capabilities of cell sorting systems. AI and machine learning algorithms enable real-time analysis of complex cellular characteristics, improving sorting accuracy and reducing manual intervention for isolating rare cell populations. According to the International Society of Automation (ISA), its 2024 annual report, released in March 2025, highlighted a 42% growth in membership and a 62% increase in revenue since 2021, reflecting a broad industrial embrace of automation technologies. Deepcell also announced in March 2025 a collaboration with Mayo Clinic, aiming to improve IVF through its AI-driven, label-free sorting technology, demonstrating a direct clinical application of this advancement.

A distinct market trend involves the shift towards compact and portable cell sorters. This development addresses the demand for increased accessibility, reduced operational footprint, and decentralized applications, making advanced cell sorting available beyond large, centralized research facilities. Such smaller, often benchtop, instruments extend utility to academic laboratories and clinical settings, reducing the need for extensive infrastructure. The Urgent Care Association reported approximately 14,075 urgent care centers in the U. S. by the end of 2022, a 22.6% growth from 2019, underscoring the expanding need for accessible diagnostic tools in decentralized healthcare environments. NanoCellect Biomedical further supported this trend by launching its VERLO Image-Guided Cell Sorter in July 2024, emphasizing its affordable, compact, and easy-to-use benchtop design.

Segmental Insights

The Cell Sorters segment is experiencing rapid growth within the Global Cell Sorting Market, primarily driven by continuous technological advancements enhancing precision, speed, and automation capabilities. These innovations facilitate increasingly complex research activities across immunology, cancer, and stem cell biology, expanding their adoption in academic and industrial settings. Furthermore, the rising global prevalence of chronic diseases, coupled with growing investments in cell-based therapies and personalized medicine, significantly boosts the demand for efficient cell isolation tools. This sustained expansion in both research and clinical applications underscores the critical role of advanced cell sorters in modern biological and medical sciences.

Regional Insights

North America emerges as the leading region in the global cell sorting market, driven by a highly developed healthcare infrastructure and substantial investments in biotechnology and pharmaceutical research. The region benefits from a robust research ecosystem, encompassing prominent universities and research centers, which actively fosters innovation and the adoption of advanced cell sorting technologies. Furthermore, significant government funding, particularly from institutions such as the National Institutes of Health, plays a crucial role in supporting life sciences research and the development of novel cell sorting tools and applications. This supportive environment, combined with the strong presence of key market participants, solidifies North America's dominant position.

Recent Developments

• In September 2025, a significant collaboration was announced between Akadeum Life Sciences and Charles River Laboratories International, Inc. This partnership focused on merging Akadeum’s GMP-grade Human T Cell Leukopak Isolation Kit with Charles River's Cell Therapy Flex Program. The initiative is intended to enhance the capabilities for cell separation, particularly in the context of developing therapeutic solutions. This strategic alliance highlights efforts within the global cell sorting market to integrate advanced separation technologies for the progression of cell-based therapies.

• In May 2025, Becton, Dickinson and Company (BD) launched what was described as the world's first cell analyzer to combine breakthrough spectral and real-time cell imaging technologies. This innovative instrument was developed to enable researchers to gain deeper insights into cellular dynamics and uncover information previously undetectable in standard flow cytometry experiments. This product launch directly contributes to the technological advancements in the global cell sorting market by providing more comprehensive analytical capabilities for cellular research.

• In July 2024, NanoCellect Biomedical launched its VERLO™ Image-Guided Cell Sorter. This new product, rooted in microfluidic cell sorting technology, was positioned to significantly advance the fields of single-cell visualization, gentle flow cytometry analysis, and cell sorting. The VERLO system represents a notable technological leap in the precision and efficacy of cell isolation techniques. This introduction by NanoCellect Biomedical underscores ongoing innovation within the global cell sorting market, providing researchers with enhanced tools for cellular analysis.

• In April 2024, Becton, Dickinson and Company (BD) introduced the BD FACSDiscover S8 Cell Sorter to the global market. This high-performance platform was designed to empower researchers by facilitating the confirmation of complex biological insights and the precise isolation of specific cell populations. The introduction of this cell sorter aimed to streamline intricate laboratory workflows and enhance the accuracy of biological analyses worldwide. This development marks a significant advancement in cell sorting technology, directly impacting research capabilities within the global cell sorting market.

Key Market Players

• Sony Biotechnology Inc.
• Union Biometrica, Inc.
• TERUMO BCT, Inc.
• Sysmex Europe SE
• Beckton, and Dickinson Company
• Bio-Rad Laboratories, Inc.
• Cytonome/ST, LLC
• On-chip Biotechnologies Co., Ltd
• Beckman Coulter, Inc.
• Thermo Fisher Scientific Inc.

Report Scope:

In this report, the Global Cell Sorting Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Cell Sorting Market, By Product and Services:

o   Cell Sorters

o   Reagents and Kits

o   Consumables

o   Cell Sorting Services

• Cell Sorting Market, By Technology:

o   Fluorescence- Based Droplet Cell Sorting

o   Magnetic-Activated Cell Sorting (MACS)

o   Micro-Electromechanical Systems (MEMS)–Microfluidics

• Cell Sorting Market, By Application:

o   Research

o   Clinical

• Cell Sorting Market, By End User:

o   Research Institutes

o   Pharmaceutical and Biotechnology Companies

o   Medical and Academic Institutions

o   Hospitals and Clinical

o   Others

• Cell Sorting Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Cell Sorting Market.

Available Customizations:

Global Cell Sorting Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Cell Sorting Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]